瑞普生物 (300119.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(瑞普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 1,735,389,701.381,146,139,041.73538,803,541.062,085,775,756.551,495,975,286.31996,285,350.80472,383,557.64
 收到的税费返还(元) 1,987,660.731,987,660.73638,712.445,210,958.655,180,869.593,668,977.513,030,389.40
 收到其他与经营活动有关的现金(元) 40,796,835.8725,860,310.377,920,889.3247,336,805.5738,013,529.3828,659,467.0613,826,476.92
 经营活动现金流入小计(元) 1,778,174,197.981,173,987,012.83547,363,142.822,138,323,520.771,539,169,685.281,028,613,795.37489,240,423.96
 购买商品、接受劳务支付的现金(元) 723,794,832.49509,439,633.77223,804,035.19894,019,665.73688,467,976.69444,002,418.75217,923,690.75
 支付给职工以及为职工支付的现金(元) 345,313,404.12229,921,138.26121,487,366.65422,174,153.94320,589,311.28214,635,997.30113,666,880.12
 支付的各项税费(元) 108,876,053.8781,734,929.1845,658,505.11153,533,649.85115,481,247.2885,852,267.1244,937,906.67
 支付其他与经营活动有关的现金(元) 244,066,349.78157,052,448.3367,277,306.64290,399,722.65217,663,808.75147,363,832.4583,499,774.57
 经营活动现金流出小计(元) 1,422,050,640.26978,148,149.54458,227,213.591,760,127,192.171,342,202,344.00891,854,515.62460,028,252.11
 经营活动产生的现金流量净额(元) 356,123,557.72195,838,863.2989,135,929.23378,196,328.60196,967,341.28136,759,279.7529,212,171.85
二、投资活动产生的现金流量
 收回投资收到的现金(元) 2,548,098,367.001,987,728,367.00961,680,000.003,615,577,633.002,633,148,000.001,906,548,000.001,250,200,000.00
 取得投资收益收到的现金(元) 18,709,881.2713,527,896.3711,604,070.3041,775,270.1842,886,581.3436,855,240.5115,698,861.81
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 55,449.9115,279.915,150.00159,727,001.5079,965,637.00321,856.607,814.00
 收到其他与投资活动有关的现金(元) 37,585,388.8935,185,388.8935,000,000.00212,013.25212,013.25212,013.25212,013.25
 投资活动现金流入小计(元) 2,604,449,087.072,036,456,932.171,008,289,220.303,817,291,917.932,756,212,231.591,943,937,110.361,266,118,689.06
 购建固定资产、无形资产和其他长期资产支付的现金(元) 145,259,807.69117,306,960.7154,054,625.02244,482,760.82178,779,145.09110,675,160.3856,094,613.67
 投资支付的现金(元) 2,486,890,000.001,643,350,000.00779,500,000.003,733,783,766.252,418,066,000.001,829,488,000.001,159,675,600.00
 取得子公司及其他营业单位支付的现金净额(元) 202,650,230.65202,650,230.65-----
 支付其他与投资活动有关的现金(元) 876,652.78------
 投资活动现金流出小计(元) 2,835,676,691.121,963,307,191.36833,554,625.023,978,266,527.072,596,845,145.091,940,163,160.381,215,770,213.67
 投资活动产生的现金流量净额(元) -231,227,604.0573,149,740.81174,734,595.28-160,974,609.14159,367,086.503,773,949.9850,348,475.39
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---1,000,000.001,000,000.001,000,000.00-
  其中:子公司吸收少数股东投资收到的现金(元) ---1,000,000.001,000,000.001,000,000.00-
 取得借款收到的现金(元) 698,050,000.00564,000,000.00204,000,000.00704,607,000.00485,607,000.00470,100,000.00125,600,000.00
 收到其他与筹资活动有关的现金(元) 15,000,000.0015,000,000.00-19,500,254.9513,779,754.959,500,254.959,500,254.95
 筹资活动现金流入小计(元) 713,050,000.00579,000,000.00204,000,000.00725,107,254.95500,386,754.95480,600,254.95135,100,254.95
 偿还债务支付的现金(元) 289,333,280.00529,173,705.32160,598,500.00716,498,000.00638,998,000.00513,114,000.00251,114,000.00
 分配股利、利润或偿付利息支付的现金(元) 241,578,621.49235,884,938.588,277,249.59175,481,065.71170,875,205.55163,123,830.546,925,069.59
  其中:子公司支付给少数股东的股利、利润(元) 34,994,773.8734,994,773.87-12,664,000.0012,424,000.009,172,000.00-
 支付其他与筹资活动有关的现金(元) 292,536,102.5625,898,571.5419,137,753.99105,589,177.4241,208,592.4639,544,743.6811,346,817.45
 筹资活动现金流出小计(元) 823,448,004.05790,957,215.44188,013,503.58997,568,243.13851,081,798.01715,782,574.22269,385,887.04
 筹资活动产生的现金流量净额(元) -110,398,004.05-211,957,215.4415,986,496.42-272,460,988.18-350,695,043.06-235,182,319.27-134,285,632.09
四、汇率变动对现金及现金等价物的影响(元) 392,159.94355,470.6959,671.0364,250.4854,806.2942,838.5223,388.14
五、现金及现金等价物净增加额(元) 14,890,109.5657,386,859.35279,916,691.96-55,175,018.245,694,191.01-94,606,251.02-54,701,596.71
 加:期初现金及现金等价物余额(元) 321,529,914.70321,529,914.70321,529,914.70376,704,932.94376,704,932.94376,704,932.94376,704,932.94
 期末现金及现金等价物余额(元) 336,420,024.26378,916,774.05601,446,606.66321,529,914.70382,399,123.95282,098,681.92322,003,336.23
补充资料:
 净利润(元) -167,808,511.44-511,016,725.18-193,473,913.00-
 资产减值准备(元) -8,892,111.47-28,397,699.15-8,346,342.08-
 固定资产和投资性房地产折旧(元) -70,704,252.50-115,197,115.16-53,074,539.13-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -70,704,252.50-115,197,115.16-53,074,539.13-
 无形资产摊销(元) -17,177,581.14-23,226,694.97-11,198,262.86-
 长期待摊费用摊销(元) -170,287.86-559,719.82-334,087.44-
 处置固定资产、无形资产和其他长期资产的损失(元) -764.95--114,086,414.40--76,697.88-
 固定资产报废损失(元) -52,807.58-491,978.90-275,888.38-
 公允价值变动损失(元) --14,891,764.47--61,259,889.12--21,961,740.08-
 财务费用(元) -13,330,968.70-21,082,289.12-12,312,317.49-
 投资损失(元) --1,643,608.10--15,150,590.17--21,393,115.52-
 递延所得税(元) -38,193,293.25-21,987,999.45-9,140,190.58-
  其中:递延所得税资产减少(元) --7,950,197.34--2,207,242.53--719,730.97-
 递延所得税负债增加(元) -46,143,490.59-24,195,241.98-9,859,921.55-
 存货的减少(元) --3,267,544.05--22,295,577.74--36,115,483.14-
 经营性应收项目的减少(元) --107,777,188.23--186,752,667.24--71,837,473.53-
 经营性应付项目的增加(元) -10,637,098.60-38,502,557.60--7,085,695.44-
 其他(元) --7,555,124.03-11,224,462.62-3,229,913.14-
 现金的期末余额(元) -378,916,774.05-321,529,914.70-282,098,681.92-
 减:现金的期初余额(元) -321,529,914.70-376,704,932.94-376,704,932.94-
 现金及现金等价物的净增加额(元) -57,386,859.35--55,175,018.24--94,606,251.02-
公告日期 2024-10-302024-08-242024-04-262024-03-302023-10-262023-08-262023-04-27
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院